Aptamers as therapeutic and diagnostic reagents: problems and prospects.
暂无分享,去创建一个
[1] In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. , 1995, Chemistry & biology.
[2] Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. Vargeese,et al. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. , 1995, Biochemistry.
[4] N. Janjić,et al. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. , 1995, Chemistry & biology.
[5] Michael R. Green,et al. HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA , 1991, Cell.
[6] L E Orgel,et al. Selection in vitro , 1979, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[7] Y. Lin,et al. Modified RNA sequence pools for in vitro selection. , 1994, Nucleic acids research.
[8] A D Ellington,et al. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo , 1996, Journal of virology.
[9] S D Jayasena,et al. Use of a high affinity DNA ligand in flow cytometry. , 1996, Nucleic acids research.
[10] J. Latham,et al. The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. , 1994, Nucleic acids research.
[11] E. Vermaas,et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.
[12] L. Gold,et al. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. , 1995, Biochemistry.
[13] J. Wills,et al. Isolation of virus-neutralizing RNAs from a large pool of random sequences. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] L. Gold,et al. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus. , 1996, Biochemistry.
[15] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[16] M Yarus,et al. Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.
[17] A D Ellington,et al. Detecting immobilized protein kinase C isozymes with RNA aptamers. , 1996, Analytical biochemistry.
[18] N. Janjić,et al. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. , 1994, Biochemistry.
[19] Design, synthesis, and analysis of disulfide cross-linked DNA duplexes , 1996 .
[20] L. C. Bock,et al. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. , 1993, Blood.
[21] N. Janjić,et al. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] A D Ellington,et al. Isozyme-specific inhibition of protein kinase C by RNA aptamers. , 1994, The Journal of biological chemistry.
[23] J. Kinet,et al. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. , 1996, Journal of immunology.
[24] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[25] L. Gold,et al. Let's get specific: the relationship between specificity and affinity. , 1995, Chemistry & biology.
[26] Robert L. Letsinger,et al. Use of a Stilbenedicarboxamide Bridge in Stabilizing, Monitoring, and Photochemically Altering Folded Conformations of Oligonucleotides , 1995 .
[27] T. Fitzwater,et al. Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor , 1997, Nature Biotechnology.
[28] D. Drolet,et al. An enzyme-linked oligonucleotide assay , 1996, Nature Biotechnology.
[29] Andrew D. Ellington,et al. Nucleic Acid Selection and the Challenge of Combinatorial Chemistry. , 1997, Chemical reviews.
[30] A. Ellington,et al. Incorporation of a non-nucleotide bridge into hairpin oligonucleotides capable of high-affinity binding to the Rev protein of HIV-1. , 1996, Biochemistry.
[31] L. Gold,et al. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Engelke,et al. Expression of small, therapeutic RNAs in human cell nuclei , 1997, Gene Therapy.
[33] A. Ellington,et al. In vitro selection of aptamers: the dearth of pure reason. , 1996, Current opinion in structural biology.
[34] A. Bertelsen,et al. Structural and functional characterization of potent antithrombotic oligonucleotides possessing both quadruplex and duplex motifs. , 1995, Biochemistry.